104 related articles for article (PubMed ID: 14565290)
1. Synthesis and antiviral activity assay of novel (E)-3',5'-diamino-5-(2-bromovinyl)-2',3',5'-trideoxyuridine.
Lavandera I; Fernández S; Ferrero M; De Clercq E; Gotor V
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):833-6. PubMed ID: 14565290
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antiviral activity of (E)-5-(2-bromovinyl)uracil and (E)-5-(2-bromovinyl)uridine.
De Clercq E; Desgranges C; Herdewijn P; Sim IS; Jones AS; McLean MJ; Walker RT
J Med Chem; 1986 Feb; 29(2):213-7. PubMed ID: 3005566
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Harris SA; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2001 Sep; 12(5):293-300. PubMed ID: 11900348
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, protonation behavior, conformational analysis, and regioselective enzymatic acylation of the novel diamino analogue of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
Lavandera I; Fernández S; Ferrero M; De Clercq E; Gotor V
Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1939-52. PubMed ID: 14609233
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses.
Choi Y; Li L; Grill S; Gullen E; Lee CS; Gumina G; Tsujii E; Cheng YC; Chu CK
J Med Chem; 2000 Jun; 43(13):2538-46. PubMed ID: 10891113
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
[TBL] [Abstract][Full Text] [Related]
8. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU).
De Clercq E
Med Res Rev; 2005 Jan; 25(1):1-20. PubMed ID: 15389733
[TBL] [Abstract][Full Text] [Related]
9. Simple synthesis and anti-HIV activity of novel 3'-vinyl branched apiosyl pyrimidine nucleosides.
Oh CH; Kim JW; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):871-8. PubMed ID: 16901819
[TBL] [Abstract][Full Text] [Related]
10. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
De Clercq E
Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
[TBL] [Abstract][Full Text] [Related]
11. Efficient syntheses of (E)-5-(2-bromovinyl)-2'-deoxy-4'-thiouridine; a nucleoside analogue with potent biological activity.
Basnak I; Otter GP; Duncombe RJ; Westwood NB; Pietrarelli M; Hardy GW; Mills G; Rahim SG; Walker RT
Nucleosides Nucleotides; 1998; 17(1-3):29-38. PubMed ID: 9708340
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate potentiates anti-herpes simplex virus type 1 activity of E-5-(2-bromovinyl)-2'-deoxyuridine.
Pancheva SN
Acta Virol; 1995 Apr; 39(2):117-9. PubMed ID: 7676937
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of cationic beta-vinyl substituted meso-tetraphenylporphyrins and their in vitro activity against herpes simplex virus type 1.
Silva EM; Giuntini F; Faustino MA; Tomé JP; Neves MG; Tomé AC; Silva AM; Santana-Marques MG; Ferrer-Correia AJ; Cavaleiro JA; Caeiro MF; Duarte RR; Tavares SA; Pegado IN; d'Almeida B; De Matos AP; Valdeira ML
Bioorg Med Chem Lett; 2005 Jul; 15(14):3333-7. PubMed ID: 15951174
[TBL] [Abstract][Full Text] [Related]
14. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
Degrève B; De Clercq E; Balzarini J
Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral properties of (E)-5-(2-bromovinyl)-2'-deoxycytidine-related compounds.
Jones AS; Sayers JR; Walker RT; De Clercq E
J Med Chem; 1988 Jan; 31(1):268-71. PubMed ID: 2826786
[TBL] [Abstract][Full Text] [Related]
16. Highly selective cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine derivatives for murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Seno T
Mol Pharmacol; 1985 Dec; 28(6):581-7. PubMed ID: 3001499
[TBL] [Abstract][Full Text] [Related]
17. Comparative metabolism of E-5-(2-bromovinyl)-2'-deoxyuridine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil in herpes simplex virus-infected cells.
Ayisi NK; Wall RA; Wanklin RJ; Machida H; De Clercq E; Sacks SL
Mol Pharmacol; 1987 Apr; 31(4):422-9. PubMed ID: 3472064
[TBL] [Abstract][Full Text] [Related]
18. Selective synthesis and application to the synthesis of (E)-fluorovinyl nucleosides.
Shen Q; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2008 Mar; 27(3):213-23. PubMed ID: 18260007
[TBL] [Abstract][Full Text] [Related]
19. cis-trans-isomerization of [E]-5-(2-bromovinyl)-2,2'-anhydrouridine in vivo in rats.
Szinai I; Veres Z; Szabolcs A; Gács-Baitz E; Ujszászy K; Dénes G
Xenobiotica; 1991 Mar; 21(3):359-69. PubMed ID: 1650515
[TBL] [Abstract][Full Text] [Related]
20. A thymidine phosphorylase-stable analogue of BVDU with significant antiviral activity.
Guenther S; Balzarini J; De Clercq E; Nair V
J Med Chem; 2002 Dec; 45(25):5426-9. PubMed ID: 12459010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
